nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—psoriasis	0.611	1	CbGaD
Pseudoephedrine—IL2—synovial fluid—psoriasis	0.0508	0.83	CbGeAlD
Pseudoephedrine—IL2—skin of body—psoriasis	0.00497	0.0811	CbGeAlD
Pseudoephedrine—NFATC1—tendon—psoriasis	0.00413	0.0675	CbGeAlD
Pseudoephedrine—MAOA—tendon—psoriasis	0.000742	0.0121	CbGeAlD
Pseudoephedrine—ADRA2A—tendon—psoriasis	0.00057	0.0093	CbGeAlD
Pseudoephedrine—Dermatitis—Calcitriol—psoriasis	0.000337	0.00294	CcSEcCtD
Pseudoephedrine—Headache—Calcitriol—psoriasis	0.000335	0.00292	CcSEcCtD
Pseudoephedrine—Dyspnoea—Hydroxyurea—psoriasis	0.000333	0.0029	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Prednisone—psoriasis	0.000332	0.0029	CcSEcCtD
Pseudoephedrine—Hypertension—Mycophenolic acid—psoriasis	0.000331	0.00288	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisolone—psoriasis	0.00033	0.00288	CcSEcCtD
Pseudoephedrine—Dyspepsia—Hydroxyurea—psoriasis	0.000328	0.00286	CcSEcCtD
Pseudoephedrine—Chest pain—Mycophenolic acid—psoriasis	0.000326	0.00284	CcSEcCtD
Pseudoephedrine—Anxiety—Mycophenolic acid—psoriasis	0.000325	0.00283	CcSEcCtD
Pseudoephedrine—Irritability—Prednisone—psoriasis	0.000325	0.00283	CcSEcCtD
Pseudoephedrine—Decreased appetite—Hydroxyurea—psoriasis	0.000324	0.00283	CcSEcCtD
Pseudoephedrine—Bradycardia—Hydrocortisone—psoriasis	0.000322	0.00281	CcSEcCtD
Pseudoephedrine—Pain—Hydroxyurea—psoriasis	0.000319	0.00278	CcSEcCtD
Pseudoephedrine—Arrhythmia—Cyclosporine—psoriasis	0.000318	0.00277	CcSEcCtD
Pseudoephedrine—Nausea—Calcitriol—psoriasis	0.000317	0.00277	CcSEcCtD
Pseudoephedrine—Confusional state—Mycophenolic acid—psoriasis	0.000315	0.00275	CcSEcCtD
Pseudoephedrine—Hallucination—Hydrocortisone—psoriasis	0.000315	0.00274	CcSEcCtD
Pseudoephedrine—Dizziness—Acitretin—psoriasis	0.000314	0.00274	CcSEcCtD
Pseudoephedrine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000313	0.00273	CcSEcCtD
Pseudoephedrine—Arrhythmia—Mycophenolate mofetil—psoriasis	0.00031	0.0027	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Hydroxyurea—psoriasis	0.000308	0.00268	CcSEcCtD
Pseudoephedrine—Tachycardia—Mycophenolic acid—psoriasis	0.000305	0.00266	CcSEcCtD
Pseudoephedrine—Tension—Cyclosporine—psoriasis	0.000304	0.00265	CcSEcCtD
Pseudoephedrine—Bradycardia—Triamcinolone—psoriasis	0.000303	0.00264	CcSEcCtD
Pseudoephedrine—Vomiting—Acitretin—psoriasis	0.000302	0.00264	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Mycophenolic acid—psoriasis	0.000302	0.00263	CcSEcCtD
Pseudoephedrine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000301	0.00263	CcSEcCtD
Pseudoephedrine—Nervousness—Cyclosporine—psoriasis	0.000301	0.00262	CcSEcCtD
Pseudoephedrine—Rash—Acitretin—psoriasis	0.0003	0.00261	CcSEcCtD
Pseudoephedrine—Dermatitis—Acitretin—psoriasis	0.000299	0.00261	CcSEcCtD
Pseudoephedrine—Rash—Fluocinolone Acetonide—psoriasis	0.000299	0.00261	CcSEcCtD
Pseudoephedrine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000299	0.0026	CcSEcCtD
Pseudoephedrine—Anorexia—Mycophenolic acid—psoriasis	0.000298	0.0026	CcSEcCtD
Pseudoephedrine—Muscle spasms—Cyclosporine—psoriasis	0.000298	0.0026	CcSEcCtD
Pseudoephedrine—Headache—Acitretin—psoriasis	0.000298	0.0026	CcSEcCtD
Pseudoephedrine—Headache—Fluocinolone Acetonide—psoriasis	0.000297	0.00259	CcSEcCtD
Pseudoephedrine—Tension—Mycophenolate mofetil—psoriasis	0.000297	0.00259	CcSEcCtD
Pseudoephedrine—Body temperature increased—Hydroxyurea—psoriasis	0.000295	0.00257	CcSEcCtD
Pseudoephedrine—Nervousness—Mycophenolate mofetil—psoriasis	0.000294	0.00256	CcSEcCtD
Pseudoephedrine—Muscle spasms—Mycophenolate mofetil—psoriasis	0.000291	0.00253	CcSEcCtD
Pseudoephedrine—Tremor—Cyclosporine—psoriasis	0.00029	0.00253	CcSEcCtD
Pseudoephedrine—Arrhythmia—Prednisolone—psoriasis	0.000289	0.00252	CcSEcCtD
Pseudoephedrine—Agitation—Cyclosporine—psoriasis	0.000285	0.00248	CcSEcCtD
Pseudoephedrine—Tremor—Mycophenolate mofetil—psoriasis	0.000283	0.00247	CcSEcCtD
Pseudoephedrine—Insomnia—Mycophenolic acid—psoriasis	0.000283	0.00247	CcSEcCtD
Pseudoephedrine—Arrhythmia—Hydrocortisone—psoriasis	0.000283	0.00246	CcSEcCtD
Pseudoephedrine—Nausea—Acitretin—psoriasis	0.000282	0.00246	CcSEcCtD
Pseudoephedrine—Nausea—Fluocinolone Acetonide—psoriasis	0.000282	0.00246	CcSEcCtD
Pseudoephedrine—Dyspnoea—Mycophenolic acid—psoriasis	0.000279	0.00243	CcSEcCtD
Pseudoephedrine—Vertigo—Cyclosporine—psoriasis	0.000278	0.00243	CcSEcCtD
Pseudoephedrine—Agitation—Mycophenolate mofetil—psoriasis	0.000278	0.00242	CcSEcCtD
Pseudoephedrine—Dyspepsia—Mycophenolic acid—psoriasis	0.000275	0.0024	CcSEcCtD
Pseudoephedrine—Bradycardia—Betamethasone—psoriasis	0.000275	0.0024	CcSEcCtD
Pseudoephedrine—Bradycardia—Dexamethasone—psoriasis	0.000275	0.0024	CcSEcCtD
Pseudoephedrine—Decreased appetite—Mycophenolic acid—psoriasis	0.000272	0.00237	CcSEcCtD
Pseudoephedrine—Vertigo—Mycophenolate mofetil—psoriasis	0.000272	0.00237	CcSEcCtD
Pseudoephedrine—Irritability—Methotrexate—psoriasis	0.000271	0.00237	CcSEcCtD
Pseudoephedrine—Hallucination—Betamethasone—psoriasis	0.000269	0.00234	CcSEcCtD
Pseudoephedrine—Hallucination—Dexamethasone—psoriasis	0.000269	0.00234	CcSEcCtD
Pseudoephedrine—Asthenia—Hydroxyurea—psoriasis	0.000268	0.00233	CcSEcCtD
Pseudoephedrine—Hypertension—Cyclosporine—psoriasis	0.000267	0.00233	CcSEcCtD
Pseudoephedrine—Pain—Mycophenolic acid—psoriasis	0.000267	0.00233	CcSEcCtD
Pseudoephedrine—Palpitations—Mycophenolate mofetil—psoriasis	0.000267	0.00233	CcSEcCtD
Pseudoephedrine—Arrhythmia—Triamcinolone—psoriasis	0.000266	0.00232	CcSEcCtD
Pseudoephedrine—Chest pain—Cyclosporine—psoriasis	0.000264	0.0023	CcSEcCtD
Pseudoephedrine—Anxiety—Cyclosporine—psoriasis	0.000263	0.00229	CcSEcCtD
Pseudoephedrine—Hypertension—Mycophenolate mofetil—psoriasis	0.000261	0.00228	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000258	0.00225	CcSEcCtD
Pseudoephedrine—Chest pain—Mycophenolate mofetil—psoriasis	0.000257	0.00224	CcSEcCtD
Pseudoephedrine—Anxiety—Mycophenolate mofetil—psoriasis	0.000256	0.00224	CcSEcCtD
Pseudoephedrine—Confusional state—Cyclosporine—psoriasis	0.000255	0.00222	CcSEcCtD
Pseudoephedrine—Vertigo—Prednisolone—psoriasis	0.000253	0.00221	CcSEcCtD
Pseudoephedrine—Confusional state—Mycophenolate mofetil—psoriasis	0.000249	0.00217	CcSEcCtD
Pseudoephedrine—Vertigo—Hydrocortisone—psoriasis	0.000247	0.00216	CcSEcCtD
Pseudoephedrine—Body temperature increased—Mycophenolic acid—psoriasis	0.000247	0.00215	CcSEcCtD
Pseudoephedrine—Dizziness—Hydroxyurea—psoriasis	0.000247	0.00215	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Cyclosporine—psoriasis	0.000244	0.00213	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisolone—psoriasis	0.000243	0.00212	CcSEcCtD
Pseudoephedrine—Arrhythmia—Dexamethasone—psoriasis	0.000241	0.00211	CcSEcCtD
Pseudoephedrine—Arrhythmia—Betamethasone—psoriasis	0.000241	0.00211	CcSEcCtD
Pseudoephedrine—Anorexia—Cyclosporine—psoriasis	0.000241	0.0021	CcSEcCtD
Pseudoephedrine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000241	0.0021	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisone—psoriasis	0.00024	0.00209	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000238	0.00208	CcSEcCtD
Pseudoephedrine—Hypertension—Hydrocortisone—psoriasis	0.000238	0.00207	CcSEcCtD
Pseudoephedrine—Vomiting—Hydroxyurea—psoriasis	0.000237	0.00207	CcSEcCtD
Pseudoephedrine—Rash—Hydroxyurea—psoriasis	0.000235	0.00205	CcSEcCtD
Pseudoephedrine—Anorexia—Mycophenolate mofetil—psoriasis	0.000235	0.00205	CcSEcCtD
Pseudoephedrine—Dermatitis—Hydroxyurea—psoriasis	0.000235	0.00205	CcSEcCtD
Pseudoephedrine—Hallucination—Prednisone—psoriasis	0.000234	0.00204	CcSEcCtD
Pseudoephedrine—Headache—Hydroxyurea—psoriasis	0.000234	0.00204	CcSEcCtD
Pseudoephedrine—Anxiety—Hydrocortisone—psoriasis	0.000234	0.00204	CcSEcCtD
Pseudoephedrine—Vertigo—Triamcinolone—psoriasis	0.000233	0.00203	CcSEcCtD
Pseudoephedrine—Dysuria—Methotrexate—psoriasis	0.00023	0.002	CcSEcCtD
Pseudoephedrine—Insomnia—Cyclosporine—psoriasis	0.000229	0.00199	CcSEcCtD
Pseudoephedrine—Dyspnoea—Cyclosporine—psoriasis	0.000225	0.00197	CcSEcCtD
Pseudoephedrine—Tachycardia—Prednisolone—psoriasis	0.000225	0.00196	CcSEcCtD
Pseudoephedrine—Asthenia—Mycophenolic acid—psoriasis	0.000224	0.00196	CcSEcCtD
Pseudoephedrine—Hypertension—Triamcinolone—psoriasis	0.000224	0.00195	CcSEcCtD
Pseudoephedrine—Insomnia—Mycophenolate mofetil—psoriasis	0.000223	0.00195	CcSEcCtD
Pseudoephedrine—Dyspepsia—Cyclosporine—psoriasis	0.000223	0.00194	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisolone—psoriasis	0.000222	0.00194	CcSEcCtD
Pseudoephedrine—Nausea—Hydroxyurea—psoriasis	0.000222	0.00193	CcSEcCtD
Pseudoephedrine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00022	0.00192	CcSEcCtD
Pseudoephedrine—Decreased appetite—Cyclosporine—psoriasis	0.00022	0.00192	CcSEcCtD
Pseudoephedrine—Tachycardia—Hydrocortisone—psoriasis	0.000219	0.00191	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000217	0.00189	CcSEcCtD
Pseudoephedrine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000217	0.00189	CcSEcCtD
Pseudoephedrine—Pain—Cyclosporine—psoriasis	0.000216	0.00189	CcSEcCtD
Pseudoephedrine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000214	0.00187	CcSEcCtD
Pseudoephedrine—Anorexia—Hydrocortisone—psoriasis	0.000214	0.00187	CcSEcCtD
Pseudoephedrine—Vertigo—Betamethasone—psoriasis	0.000211	0.00184	CcSEcCtD
Pseudoephedrine—Vertigo—Dexamethasone—psoriasis	0.000211	0.00184	CcSEcCtD
Pseudoephedrine—Pain—Mycophenolate mofetil—psoriasis	0.000211	0.00184	CcSEcCtD
Pseudoephedrine—Arrhythmia—Prednisone—psoriasis	0.00021	0.00183	CcSEcCtD
Pseudoephedrine—Sweating—Methotrexate—psoriasis	0.00021	0.00183	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Cyclosporine—psoriasis	0.000208	0.00182	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisolone—psoriasis	0.000208	0.00181	CcSEcCtD
Pseudoephedrine—Dizziness—Mycophenolic acid—psoriasis	0.000207	0.0018	CcSEcCtD
Pseudoephedrine—Tachycardia—Triamcinolone—psoriasis	0.000206	0.0018	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Triamcinolone—psoriasis	0.000205	0.00178	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000203	0.00177	CcSEcCtD
Pseudoephedrine—Insomnia—Hydrocortisone—psoriasis	0.000203	0.00177	CcSEcCtD
Pseudoephedrine—Hypertension—Dexamethasone—psoriasis	0.000203	0.00177	CcSEcCtD
Pseudoephedrine—Hypertension—Betamethasone—psoriasis	0.000203	0.00177	CcSEcCtD
Pseudoephedrine—Body temperature increased—Cyclosporine—psoriasis	0.0002	0.00174	CcSEcCtD
Pseudoephedrine—Anxiety—Dexamethasone—psoriasis	0.0002	0.00174	CcSEcCtD
Pseudoephedrine—Anxiety—Betamethasone—psoriasis	0.0002	0.00174	CcSEcCtD
Pseudoephedrine—Vomiting—Mycophenolic acid—psoriasis	0.000199	0.00173	CcSEcCtD
Pseudoephedrine—Dyspepsia—Hydrocortisone—psoriasis	0.000198	0.00173	CcSEcCtD
Pseudoephedrine—Rash—Mycophenolic acid—psoriasis	0.000197	0.00172	CcSEcCtD
Pseudoephedrine—Dermatitis—Mycophenolic acid—psoriasis	0.000197	0.00172	CcSEcCtD
Pseudoephedrine—Pain—Prednisolone—psoriasis	0.000197	0.00172	CcSEcCtD
Pseudoephedrine—Headache—Mycophenolic acid—psoriasis	0.000196	0.00171	CcSEcCtD
Pseudoephedrine—Decreased appetite—Hydrocortisone—psoriasis	0.000195	0.0017	CcSEcCtD
Pseudoephedrine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000195	0.0017	CcSEcCtD
Pseudoephedrine—Pain—Hydrocortisone—psoriasis	0.000192	0.00168	CcSEcCtD
Pseudoephedrine—Insomnia—Triamcinolone—psoriasis	0.000191	0.00167	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Prednisolone—psoriasis	0.00019	0.00165	CcSEcCtD
Pseudoephedrine—Dyspnoea—Triamcinolone—psoriasis	0.000189	0.00165	CcSEcCtD
Pseudoephedrine—Agitation—Prednisone—psoriasis	0.000188	0.00164	CcSEcCtD
Pseudoephedrine—Tachycardia—Dexamethasone—psoriasis	0.000187	0.00163	CcSEcCtD
Pseudoephedrine—Tachycardia—Betamethasone—psoriasis	0.000187	0.00163	CcSEcCtD
Pseudoephedrine—Dyspepsia—Triamcinolone—psoriasis	0.000186	0.00162	CcSEcCtD
Pseudoephedrine—Nausea—Mycophenolic acid—psoriasis	0.000186	0.00162	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Betamethasone—psoriasis	0.000186	0.00162	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Dexamethasone—psoriasis	0.000186	0.00162	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Hydrocortisone—psoriasis	0.000185	0.00161	CcSEcCtD
Pseudoephedrine—Vertigo—Prednisone—psoriasis	0.000184	0.00161	CcSEcCtD
Pseudoephedrine—Anorexia—Dexamethasone—psoriasis	0.000183	0.0016	CcSEcCtD
Pseudoephedrine—Anorexia—Betamethasone—psoriasis	0.000183	0.0016	CcSEcCtD
Pseudoephedrine—Asthenia—Cyclosporine—psoriasis	0.000181	0.00158	CcSEcCtD
Pseudoephedrine—Pain—Triamcinolone—psoriasis	0.000181	0.00158	CcSEcCtD
Pseudoephedrine—Body temperature increased—Hydrocortisone—psoriasis	0.000178	0.00155	CcSEcCtD
Pseudoephedrine—Asthenia—Mycophenolate mofetil—psoriasis	0.000177	0.00154	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisone—psoriasis	0.000177	0.00154	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Triamcinolone—psoriasis	0.000174	0.00152	CcSEcCtD
Pseudoephedrine—Anxiety—Prednisone—psoriasis	0.000174	0.00152	CcSEcCtD
Pseudoephedrine—Insomnia—Dexamethasone—psoriasis	0.000174	0.00151	CcSEcCtD
Pseudoephedrine—Insomnia—Betamethasone—psoriasis	0.000174	0.00151	CcSEcCtD
Pseudoephedrine—Dyspepsia—Dexamethasone—psoriasis	0.000169	0.00147	CcSEcCtD
Pseudoephedrine—Dyspepsia—Betamethasone—psoriasis	0.000169	0.00147	CcSEcCtD
Pseudoephedrine—Body temperature increased—Triamcinolone—psoriasis	0.000167	0.00146	CcSEcCtD
Pseudoephedrine—Dizziness—Cyclosporine—psoriasis	0.000167	0.00146	CcSEcCtD
Pseudoephedrine—Decreased appetite—Betamethasone—psoriasis	0.000167	0.00146	CcSEcCtD
Pseudoephedrine—Decreased appetite—Dexamethasone—psoriasis	0.000167	0.00146	CcSEcCtD
Pseudoephedrine—Pain—Betamethasone—psoriasis	0.000164	0.00143	CcSEcCtD
Pseudoephedrine—Pain—Dexamethasone—psoriasis	0.000164	0.00143	CcSEcCtD
Pseudoephedrine—Tachycardia—Prednisone—psoriasis	0.000163	0.00142	CcSEcCtD
Pseudoephedrine—Dizziness—Mycophenolate mofetil—psoriasis	0.000163	0.00142	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisone—psoriasis	0.000162	0.00141	CcSEcCtD
Pseudoephedrine—Asthenia—Hydrocortisone—psoriasis	0.000161	0.00141	CcSEcCtD
Pseudoephedrine—Vomiting—Cyclosporine—psoriasis	0.000161	0.0014	CcSEcCtD
Pseudoephedrine—Rash—Cyclosporine—psoriasis	0.000159	0.00139	CcSEcCtD
Pseudoephedrine—Anorexia—Prednisone—psoriasis	0.000159	0.00139	CcSEcCtD
Pseudoephedrine—Dermatitis—Cyclosporine—psoriasis	0.000159	0.00139	CcSEcCtD
Pseudoephedrine—Headache—Cyclosporine—psoriasis	0.000158	0.00138	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Betamethasone—psoriasis	0.000158	0.00138	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Dexamethasone—psoriasis	0.000158	0.00138	CcSEcCtD
Pseudoephedrine—Vomiting—Mycophenolate mofetil—psoriasis	0.000157	0.00137	CcSEcCtD
Pseudoephedrine—Rash—Mycophenolate mofetil—psoriasis	0.000156	0.00136	CcSEcCtD
Pseudoephedrine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000155	0.00136	CcSEcCtD
Pseudoephedrine—Headache—Mycophenolate mofetil—psoriasis	0.000155	0.00135	CcSEcCtD
Pseudoephedrine—Vertigo—Methotrexate—psoriasis	0.000154	0.00134	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisolone—psoriasis	0.000152	0.00133	CcSEcCtD
Pseudoephedrine—Asthenia—Triamcinolone—psoriasis	0.000152	0.00132	CcSEcCtD
Pseudoephedrine—Body temperature increased—Dexamethasone—psoriasis	0.000152	0.00132	CcSEcCtD
Pseudoephedrine—Body temperature increased—Betamethasone—psoriasis	0.000152	0.00132	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisone—psoriasis	0.000151	0.00132	CcSEcCtD
Pseudoephedrine—Nausea—Cyclosporine—psoriasis	0.00015	0.00131	CcSEcCtD
Pseudoephedrine—Dizziness—Hydrocortisone—psoriasis	0.000149	0.0013	CcSEcCtD
Pseudoephedrine—Dyspepsia—Prednisone—psoriasis	0.000147	0.00128	CcSEcCtD
Pseudoephedrine—Nausea—Mycophenolate mofetil—psoriasis	0.000147	0.00128	CcSEcCtD
Pseudoephedrine—Chest pain—Methotrexate—psoriasis	0.000146	0.00127	CcSEcCtD
Pseudoephedrine—Decreased appetite—Prednisone—psoriasis	0.000145	0.00127	CcSEcCtD
Pseudoephedrine—Rash—Prednisolone—psoriasis	0.000145	0.00127	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisolone—psoriasis	0.000145	0.00126	CcSEcCtD
Pseudoephedrine—Headache—Prednisolone—psoriasis	0.000144	0.00126	CcSEcCtD
Pseudoephedrine—Vomiting—Hydrocortisone—psoriasis	0.000143	0.00125	CcSEcCtD
Pseudoephedrine—Rash—Hydrocortisone—psoriasis	0.000142	0.00124	CcSEcCtD
Pseudoephedrine—Dermatitis—Hydrocortisone—psoriasis	0.000142	0.00123	CcSEcCtD
Pseudoephedrine—Confusional state—Methotrexate—psoriasis	0.000141	0.00123	CcSEcCtD
Pseudoephedrine—Headache—Hydrocortisone—psoriasis	0.000141	0.00123	CcSEcCtD
Pseudoephedrine—Dizziness—Triamcinolone—psoriasis	0.00014	0.00122	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Prednisone—psoriasis	0.000138	0.0012	CcSEcCtD
Pseudoephedrine—Asthenia—Dexamethasone—psoriasis	0.000138	0.0012	CcSEcCtD
Pseudoephedrine—Asthenia—Betamethasone—psoriasis	0.000138	0.0012	CcSEcCtD
Pseudoephedrine—Nausea—Prednisolone—psoriasis	0.000137	0.00119	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Methotrexate—psoriasis	0.000135	0.00118	CcSEcCtD
Pseudoephedrine—Vomiting—Triamcinolone—psoriasis	0.000135	0.00117	CcSEcCtD
Pseudoephedrine—Nausea—Hydrocortisone—psoriasis	0.000133	0.00116	CcSEcCtD
Pseudoephedrine—Rash—Triamcinolone—psoriasis	0.000133	0.00116	CcSEcCtD
Pseudoephedrine—Dermatitis—Triamcinolone—psoriasis	0.000133	0.00116	CcSEcCtD
Pseudoephedrine—Anorexia—Methotrexate—psoriasis	0.000133	0.00116	CcSEcCtD
Pseudoephedrine—Headache—Triamcinolone—psoriasis	0.000133	0.00116	CcSEcCtD
Pseudoephedrine—Body temperature increased—Prednisone—psoriasis	0.000132	0.00115	CcSEcCtD
Pseudoephedrine—Dizziness—Dexamethasone—psoriasis	0.000127	0.00111	CcSEcCtD
Pseudoephedrine—Dizziness—Betamethasone—psoriasis	0.000127	0.00111	CcSEcCtD
Pseudoephedrine—Insomnia—Methotrexate—psoriasis	0.000126	0.0011	CcSEcCtD
Pseudoephedrine—Nausea—Triamcinolone—psoriasis	0.000126	0.0011	CcSEcCtD
Pseudoephedrine—Dyspnoea—Methotrexate—psoriasis	0.000125	0.00109	CcSEcCtD
Pseudoephedrine—Dyspepsia—Methotrexate—psoriasis	0.000123	0.00107	CcSEcCtD
Pseudoephedrine—Vomiting—Dexamethasone—psoriasis	0.000122	0.00106	CcSEcCtD
Pseudoephedrine—Vomiting—Betamethasone—psoriasis	0.000122	0.00106	CcSEcCtD
Pseudoephedrine—Decreased appetite—Methotrexate—psoriasis	0.000121	0.00106	CcSEcCtD
Pseudoephedrine—Rash—Betamethasone—psoriasis	0.000121	0.00106	CcSEcCtD
Pseudoephedrine—Rash—Dexamethasone—psoriasis	0.000121	0.00106	CcSEcCtD
Pseudoephedrine—Dermatitis—Dexamethasone—psoriasis	0.000121	0.00105	CcSEcCtD
Pseudoephedrine—Dermatitis—Betamethasone—psoriasis	0.000121	0.00105	CcSEcCtD
Pseudoephedrine—Headache—Betamethasone—psoriasis	0.00012	0.00105	CcSEcCtD
Pseudoephedrine—Headache—Dexamethasone—psoriasis	0.00012	0.00105	CcSEcCtD
Pseudoephedrine—Asthenia—Prednisone—psoriasis	0.00012	0.00105	CcSEcCtD
Pseudoephedrine—Pain—Methotrexate—psoriasis	0.000119	0.00104	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Methotrexate—psoriasis	0.000115	0.001	CcSEcCtD
Pseudoephedrine—Nausea—Betamethasone—psoriasis	0.000114	0.000994	CcSEcCtD
Pseudoephedrine—Nausea—Dexamethasone—psoriasis	0.000114	0.000994	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisone—psoriasis	0.000111	0.000964	CcSEcCtD
Pseudoephedrine—Body temperature increased—Methotrexate—psoriasis	0.00011	0.000963	CcSEcCtD
Pseudoephedrine—Vomiting—Prednisone—psoriasis	0.000106	0.000927	CcSEcCtD
Pseudoephedrine—Rash—Prednisone—psoriasis	0.000105	0.000919	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisone—psoriasis	0.000105	0.000918	CcSEcCtD
Pseudoephedrine—Headache—Prednisone—psoriasis	0.000105	0.000913	CcSEcCtD
Pseudoephedrine—Asthenia—Methotrexate—psoriasis	0.0001	0.000874	CcSEcCtD
Pseudoephedrine—Nausea—Prednisone—psoriasis	9.93e-05	0.000866	CcSEcCtD
Pseudoephedrine—Dizziness—Methotrexate—psoriasis	9.24e-05	0.000806	CcSEcCtD
Pseudoephedrine—Vomiting—Methotrexate—psoriasis	8.88e-05	0.000775	CcSEcCtD
Pseudoephedrine—Rash—Methotrexate—psoriasis	8.81e-05	0.000768	CcSEcCtD
Pseudoephedrine—Dermatitis—Methotrexate—psoriasis	8.8e-05	0.000768	CcSEcCtD
Pseudoephedrine—Headache—Methotrexate—psoriasis	8.75e-05	0.000763	CcSEcCtD
Pseudoephedrine—Nausea—Methotrexate—psoriasis	8.3e-05	0.000724	CcSEcCtD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HCAR2—psoriasis	7.54e-05	0.000353	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	7.5e-05	0.000351	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD8A—psoriasis	7.39e-05	0.000346	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CD4—psoriasis	7.29e-05	0.000342	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—psoriasis	7.28e-05	0.000341	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NDUFA5—psoriasis	7.16e-05	0.000335	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-B—psoriasis	7.11e-05	0.000333	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—SOCS1—psoriasis	7.05e-05	0.00033	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—IL6—psoriasis	7.03e-05	0.000329	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HCAR2—psoriasis	7.01e-05	0.000328	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—CP—psoriasis	6.98e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCL20—psoriasis	6.93e-05	0.000325	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	6.9e-05	0.000323	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HCAR2—psoriasis	6.85e-05	0.000321	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—JUN—psoriasis	6.77e-05	0.000317	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—CARM1—psoriasis	6.66e-05	0.000312	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—psoriasis	6.65e-05	0.000312	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-A—psoriasis	6.59e-05	0.000309	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—JUN—psoriasis	6.53e-05	0.000306	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—psoriasis	6.52e-05	0.000305	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCL20—psoriasis	6.44e-05	0.000302	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	6.41e-05	0.0003	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HCAR2—psoriasis	6.37e-05	0.000298	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—psoriasis	6.33e-05	0.000297	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—CXCL8—psoriasis	6.29e-05	0.000295	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CRP—psoriasis	6.29e-05	0.000295	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—NFKB1—psoriasis	6.28e-05	0.000294	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD8A—psoriasis	6.25e-05	0.000293	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—CP—psoriasis	6.18e-05	0.00029	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	6.17e-05	0.000289	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CYP2S1—psoriasis	6.09e-05	0.000285	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HLA-A—psoriasis	6.08e-05	0.000285	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-DRB1—psoriasis	6.02e-05	0.000282	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-B—psoriasis	6.02e-05	0.000282	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.97e-05	0.00028	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IL6—psoriasis	5.95e-05	0.000279	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.91e-05	0.000277	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—CARM1—psoriasis	5.9e-05	0.000276	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—STAT3—psoriasis	5.85e-05	0.000274	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—JUN—psoriasis	5.85e-05	0.000274	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ICAM1—psoriasis	5.78e-05	0.000271	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—NFKBIA—psoriasis	5.73e-05	0.000269	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—APOE—psoriasis	5.68e-05	0.000266	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.63e-05	0.000264	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—IL6—psoriasis	5.59e-05	0.000262	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-A—psoriasis	5.57e-05	0.000261	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—JUN—psoriasis	5.55e-05	0.00026	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—JUN—psoriasis	5.53e-05	0.000259	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—JUN—psoriasis	5.51e-05	0.000258	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—IL6—psoriasis	5.39e-05	0.000253	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SOCS1—psoriasis	5.39e-05	0.000252	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—VEGFA—psoriasis	5.36e-05	0.000251	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.34e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CRP—psoriasis	5.32e-05	0.000249	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ITGAL—psoriasis	5.32e-05	0.000249	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—NFKB1—psoriasis	5.3e-05	0.000248	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NOS2—psoriasis	5.29e-05	0.000248	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.11e-05	0.000239	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-DRB1—psoriasis	5.09e-05	0.000239	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	5.07e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—psoriasis	5.06e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HCAR2—psoriasis	5e-05	0.000234	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.97e-05	0.000233	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—IL6—psoriasis	4.96e-05	0.000233	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HCAR2—psoriasis	4.89e-05	0.000229	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ICAM1—psoriasis	4.89e-05	0.000229	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—NFKBIA—psoriasis	4.85e-05	0.000227	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.85e-05	0.000227	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCL20—psoriasis	4.84e-05	0.000227	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—psoriasis	4.83e-05	0.000226	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	4.79e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NDUFA5—psoriasis	4.78e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCL20—psoriasis	4.74e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—TYK2—psoriasis	4.7e-05	0.00022	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SOCS1—psoriasis	4.56e-05	0.000214	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL6—psoriasis	4.42e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL20—psoriasis	4.4e-05	0.000206	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IFNG—psoriasis	4.4e-05	0.000206	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—TYK2—psoriasis	4.35e-05	0.000204	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.34e-05	0.000204	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TAGAP—psoriasis	4.34e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TYK2—psoriasis	4.34e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL20—psoriasis	4.3e-05	0.000202	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD4—psoriasis	4.25e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TAGAP—psoriasis	4.24e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—CXCL8—psoriasis	4.17e-05	0.000195	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—psoriasis	4.15e-05	0.000195	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	4.09e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IL6—psoriasis	4.09e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP2S1—psoriasis	4.07e-05	0.00019	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—psoriasis	4.05e-05	0.00019	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HCAR2—psoriasis	4.05e-05	0.00019	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—LEP—psoriasis	3.98e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—APOE—psoriasis	3.98e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—TYK2—psoriasis	3.97e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IL6—psoriasis	3.94e-05	0.000185	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CD4—psoriasis	3.92e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCL20—psoriasis	3.92e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—psoriasis	3.88e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	3.87e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	3.81e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—JUN—psoriasis	3.8e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CXCL8—psoriasis	3.78e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—LEP—psoriasis	3.76e-05	0.000176	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HCAR2—psoriasis	3.76e-05	0.000176	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IFNG—psoriasis	3.72e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NFKBIA—psoriasis	3.71e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—NFKB1—psoriasis	3.66e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—psoriasis	3.65e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCL20—psoriasis	3.64e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—psoriasis	3.64e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD4—psoriasis	3.59e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL20—psoriasis	3.56e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL6—psoriasis	3.53e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TAGAP—psoriasis	3.51e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—APOE—psoriasis	3.36e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—LEP—psoriasis	3.36e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL6—psoriasis	3.35e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—IL6—psoriasis	3.34e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL20—psoriasis	3.31e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—STAT3—psoriasis	3.29e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.28e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—PPARG—psoriasis	3.28e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TAGAP—psoriasis	3.26e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—JUN—psoriasis	3.21e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NFKBIA—psoriasis	3.14e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NDUFA5—psoriasis	3.12e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—NFKB1—psoriasis	3.09e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.04e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TYK2—psoriasis	3.04e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—STAT3—psoriasis	3.04e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.97e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CARM1—psoriasis	2.97e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCL8—psoriasis	2.87e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TYK2—psoriasis	2.87e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—STAT3—psoriasis	2.78e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.65e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCL8—psoriasis	2.64e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL20—psoriasis	2.6e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TYK2—psoriasis	2.57e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL20—psoriasis	2.54e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.46e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—JUN—psoriasis	2.46e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.45e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NFKB1—psoriasis	2.37e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL8—psoriasis	2.31e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—psoriasis	2.3e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.28e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL8—psoriasis	2.26e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NFKB1—psoriasis	2.24e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL8—psoriasis	2.24e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NOS2—psoriasis	2.18e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VEGFA—psoriasis	2.15e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—psoriasis	2.13e-05	9.96e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—STAT3—psoriasis	2.13e-05	9.96e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—psoriasis	2.12e-05	9.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL20—psoriasis	2.1e-05	9.85e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—JUN—psoriasis	2.08e-05	9.74e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VEGFA—psoriasis	2.03e-05	9.52e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—STAT3—psoriasis	2.01e-05	9.42e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NFKB1—psoriasis	2e-05	9.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CARM1—psoriasis	1.99e-05	9.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL20—psoriasis	1.95e-05	9.15e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—psoriasis	1.94e-05	9.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL8—psoriasis	1.87e-05	8.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.87e-05	8.74e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CAT—psoriasis	1.83e-05	8.56e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VEGFA—psoriasis	1.82e-05	8.51e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—STAT3—psoriasis	1.8e-05	8.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	1.74e-05	8.15e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—psoriasis	1.62e-05	7.6e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—psoriasis	1.48e-05	6.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SOCS1—psoriasis	1.43e-05	6.7e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOE—psoriasis	1.42e-05	6.65e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—psoriasis	1.41e-05	6.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SOCS1—psoriasis	1.4e-05	6.56e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—psoriasis	1.37e-05	6.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TYK2—psoriasis	1.36e-05	6.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TYK2—psoriasis	1.33e-05	6.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	1.31e-05	6.13e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CARM1—psoriasis	1.29e-05	6.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL8—psoriasis	1.28e-05	5.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—psoriasis	1.26e-05	5.92e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—psoriasis	1.26e-05	5.88e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PPARG—psoriasis	1.24e-05	5.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CAT—psoriasis	1.22e-05	5.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL8—psoriasis	1.19e-05	5.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL8—psoriasis	1.16e-05	5.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.16e-05	5.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.1e-05	5.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.08e-05	5.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.06e-05	4.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOE—psoriasis	1.06e-05	4.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEP—psoriasis	1.06e-05	4.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOE—psoriasis	1.03e-05	4.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEP—psoriasis	1.03e-05	4.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.03e-05	4.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NFKBIA—psoriasis	9.84e-06	4.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	9.83e-06	4.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NFKBIA—psoriasis	9.62e-06	4.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	9.61e-06	4.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—psoriasis	9.55e-06	4.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—psoriasis	9.49e-06	4.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	8.93e-06	4.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—psoriasis	8.54e-06	4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—psoriasis	8.54e-06	4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—psoriasis	8.27e-06	3.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TYK2—psoriasis	8.06e-06	3.77e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAT—psoriasis	7.96e-06	3.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	7.96e-06	3.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—psoriasis	7.94e-06	3.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—psoriasis	7.94e-06	3.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TYK2—psoriasis	7.88e-06	3.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	7.4e-06	3.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—psoriasis	7.02e-06	3.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—psoriasis	6.86e-06	3.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—psoriasis	6.67e-06	3.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—psoriasis	6.53e-06	3.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JUN—psoriasis	6.52e-06	3.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TYK2—psoriasis	6.52e-06	3.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JUN—psoriasis	6.38e-06	2.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NFKB1—psoriasis	6.28e-06	2.94e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—psoriasis	6.18e-06	2.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NFKB1—psoriasis	6.14e-06	2.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TYK2—psoriasis	6.06e-06	2.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—psoriasis	5.7e-06	2.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	5.68e-06	2.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—psoriasis	5.64e-06	2.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—psoriasis	5.57e-06	2.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—psoriasis	5.52e-06	2.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.4e-06	2.53e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—psoriasis	5.39e-06	2.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JUN—psoriasis	5.28e-06	2.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	5.27e-06	2.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	5.08e-06	2.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—psoriasis	5.02e-06	2.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JUN—psoriasis	4.9e-06	2.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	4.72e-06	2.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	4.61e-06	2.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—psoriasis	4.56e-06	2.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—psoriasis	4.31e-06	2.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	4.28e-06	2.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—psoriasis	4.24e-06	1.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—psoriasis	4.21e-06	1.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—psoriasis	3.94e-06	1.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—psoriasis	3.85e-06	1.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.48e-06	1.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—psoriasis	3.24e-06	1.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—psoriasis	3.19e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—psoriasis	2.96e-06	1.39e-05	CbGpPWpGaD
